ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

AI Briefing

• – ENA Respiratory completes Phase II study of INNA-051 nasal spray
• – INNA-051 designed to protect against symptomatic viral respiratory infections
• – Company announces successful completion of Part A and progression to Part B